Crimes Against People with Disabilities Are Increasing
Individuals with Disabilities are Four Times More Likely to be a Victim The Department of Justice recently released sobering new statistics for the disability community. According to a recent report from the department’s Bureau of Justice Statistics, between 2017 and 2019, individuals with disabilities accounted for 26% of victims of nonfatal violent crime despite only […]
Autism Impacts the Brain’s White Matter in Adolescents and Young Adults
Region Most Affected Facilitates Communication Between the Brain’s Two Hemispheres Researchers from Yale University are attempting to find neuroimaging biomarkers for autism, which could potentially help children with the disorder receive a diagnosis and treatment earlier. In order to reach this goal, the research team embarked on a study which used a special type of […]
CDC Reports: 1 in 44 American Children Have Autism
The Centers for Disease Control and Prevention (CDC) released its latest prevalence estimates for autism. The center reports that 1 in 44 or 2.27% of American 8-year-olds have an autism spectrum disorder (ASD).
Catatonia Associated with Late Regression in Autism
Mean Onset Age of Late Regression is 13 years According to the American Academy of Pediatrics, approximately 25% of cases of autism are due to early regression. This phenomenon, often referred to as regressive autism, occurs when symptoms of autism materialize after a period of normal development, typically between 18-24 months of age. Most parents […]
Sex Education for Individuals with Intellectual and Developmental Delays
People with Developmental Disabilities Lack Opportunities to Learn About Sexual Health The World Health Organization defines sexual health as a state of physical, emotional, mental and social well-being in relation to sexuality. For most people, sexual health is integral to their overall health and well-being. Individuals with intellectual and developmental disabilities (IDD), including autism, express […]
Extensive Psilocybin Trial Shows Great Promise for Treating Serious Depression
Although Small Number Serious Adverse Events Were Reported SafeMinds Shares has reported previously on psilocybin, a hallucinogenic/psychedelic substance that works by activating serotonin receptors in the prefrontal cortex, the area of the brain that affects mood, cognition, and perception. Early trials have shown that the psychedelic holds promise as an autism treatment since it supports […]
